🔬Excited to share our new publication in @natcomms.nature.com, presenting large-scale case-control evidence for BRCA1/2 variant classification 💡A major step forward in reducing VUS uncertainty in hereditary breast & ovarian cancer 🌍 Incredible teamwork across international consortia